PeptiGrowth is developing “Growth Factor Alternative Peptide” that performs equivalent function to conventional recombinant growth factors, which have some challenges such as variation in quality among production lots, contamination by biological impurities, low stability, and extremely high prices.
Our “Growth Factor Alternative Peptide” are completely manufactured by chemical synthesis to solve such challenges of conventional recombinant growth factors.
By delivering products with consistent quality across manufacturing lots, experimental data repeatability is high and with better handling characteristics and easier contaminant management at a fair price, significant efficiency improvement and cost reduction in R&D and manufacturing activities for regenerative medicine and cell therapy can be achieved. Additionally, GMP grade is also available for clinical trials.
We are committed to solving the challenges that face the pharmaceutical industry and leading the world to open the future of regenerative medicine and cell therapy.